1-3 of 3
inotuzumab ozogamicin
Close
Save search
Sort by
Journal Articles

Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia

Free
Clinical Trials & Observations
Joseph Wynne, David Wright, Wendy Stock
Journal: Blood Advances
Blood Adv (2019) 3 (1): 96–104.
https://doi.org/10.1182/bloodadvances.2018026211
Published: 2019
Journal Articles

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

Free
Clinical Trials & Observations
Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1167–1180.
https://doi.org/10.1182/bloodadvances.2016001925
Published: 2017
Includes: Supplemental data
Journal Articles

Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies

Free
Elias Jabbour, Hagop Kantarjian
Journal: Blood Advances
Blood Adv (2016) 1 (3): 260–264.
https://doi.org/10.1182/bloodadvances.2016000042
Published: 2016